Streetbeat News

Price Targets

CSL

Baird analyst Timothy Wojs has maintained an Outperform rating on Carlisle Companies (NYSE:CSL) and increased the price target from $350 to $354.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 7:37 pm

TIL

Baird analyst Jack Allen has maintained an Outperform rating on Instil Bio (NASDAQ:TIL) but has reduced the price target from $100 to $54.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 7:34 pm

MEDP

Baird analyst Eric Coldwell has maintained an Outperform rating on Medpace Holdings (NASDAQ:MEDP) and increased the price target from $302 to $312.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 7:32 pm

APLS

Baird analyst Colleen Kusy has maintained an Outperform rating on Apellis Pharmaceuticals (NASDAQ:APLS) and increased the price target from $71 to $81. This adjustment reflects a positive outlook on the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 7:30 pm

GS

JMP Securities analyst Devin Ryan has reiterated a 'Market Outperform' rating on Goldman Sachs Group (NYSE:GS) with a maintained price target of $440.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 7:25 pm

AMZN

Mizuho analyst James Lee predicts a significant expansion for Amazon in cloud and retail sectors, expecting a boom in 2024. He maintains a Buy rating on Amazon (NASDAQ:AMZN) with a price target of $220. Lee foresees accelerated growth for AWS in FY24, with enterprises planning large-scale data migrations to the cloud. He also anticipates retail margin expansion due to delivery network regionalization and new initiatives like inbound delivery decentralization and Buy with Prime. Despite a lower Q4 revenue and EPS projection compared to consensus, Lee expects a 20% revenue growth and margin expansion for Amazon in FY24.

Portfolio Pulse from Anusuya Lahiri

January 17, 2024 | 7:24 pm

CB

JMP Securities analyst Matthew Carletti has reiterated a 'Market Outperform' rating on Chubb Limited (NYSE:CB) and maintained a price target of $250. This endorsement reflects a positive outlook on Chubb's stock performance.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 7:23 pm

SKWD

JMP Securities analyst Matthew Carletti has reaffirmed a Market Outperform rating on Skyward Specialty (NASDAQ:SKWD) and increased the price target from $35 to $38.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 7:22 pm

PRA

JMP Securities analyst Matthew Carletti has maintained a Market Outperform rating on ProAssurance (NYSE:PRA) but has lowered the price target from $25 to $24.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 7:19 pm

HRTG

JMP Securities analyst Matthew Carletti has maintained a Market Outperform rating on Heritage Insurance Holdings (NYSE:HRTG) and increased the price target from $6 to $7.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 7:17 pm